1. Home
  2. HOTH vs WVVI Comparison

HOTH vs WVVI Comparison

Compare HOTH & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Logo Willamette Valley Vineyards Inc.

WVVI

Willamette Valley Vineyards Inc.

SELL

Current Price

$2.68

Market Cap

13.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
HOTH
WVVI
Founded
2017
1983
Country
United States
United States
Employees
N/A
299
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
13.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
HOTH
WVVI
Price
$1.36
$2.68
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
7.9M
2.2K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
29.69
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$2.49
52 Week High
$2.12
$7.17

Technical Indicators

Market Signals
Indicator
HOTH
WVVI
Relative Strength Index (RSI) 84.55 50.32
Support Level $1.28 $2.56
Resistance Level $1.47 $2.77
Average True Range (ATR) 0.10 0.10
MACD 0.05 -0.01
Stochastic Oscillator 81.19 49.62

Price Performance

Historical Comparison
HOTH
WVVI

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA). Its current assets are focused in treating cancer, skin toxicities, Alzheimer's, and weight loss.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: